PID Invesco International Dividend Achievers ETF Stock Quote

PID [NASD]

Invesco International Dividend Achievers ETF

Index	-	P/E	-	EPS (ttm)	-	Insider Own	-	Shs Outstand	-	Perf Week	-0.98%
Market Cap	-	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	3.11%
Income	-	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	7.69%
Sales	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	21.19%
Book/sh	-	P/B	-	EPS next Y	-	ROA	-	Target Price	-	Perf Year	6.98%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W Range	9.35 - 16.76	Perf YTD	5.80%
Dividend	0.50	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-3.12%	Beta	-
Dividend %	3.08%	Quick Ratio	-	Sales past 5Y	-	Gross Margin	-	52W Low	73.69%	ATR	0.25
Employees	-	Current Ratio	-	Sales Q/Q	-	Oper. Margin	-	RSI (14)	52.42	Volatility	1.92% 1.21%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	-	Profit Margin	-	Rel Volume	0.78	Prev Close	15.95
Shortable	Yes	LT Debt/Eq	-	Earnings	-	Payout	-	Avg Volume	97.14K	Price	16.24
Recom	-	SMA20	0.62%	SMA50	1.86%	SMA200	17.16%	Volume	76,000	Change	1.82%

Feb-07-20 02:30PM	Is Recession Knocking at the Door? ETF Strategies to Follow Zacks
Jan-21-20 08:33AM	Economic Slowdown in 2020? ETF Strategies to Help You Zacks
Aug-16-19 08:00AM	5 High-Dividend ETFs Available Under $20 Zacks
Apr-16-19 08:00AM	4 ETF Strategies to Follow Amid Global Growth Slowdown Zacks
Mar-06-18 11:03AM	7 Intelligent International Dividend ETFs for Blue-Chip Income InvestorPlace
Feb-06-18 08:10AM	Dividend plays on slippery ground as bond yields steepen Reuters
Jan-26-18 07:30AM	How Is Novartiss Subsidiary Sandoz Positioned for 2018? Market Realist
Jan-22-18 11:30AM	Behind Novartiss 4Q17 Estimates: Innovative Medicines Market Realist
Nov-14-17 01:05PM	Behind Sanofis 3Q17 Revenue Growth Market Realist
Sep-14-17 09:19AM	The Zacks Analyst Blog Highlights: SDIV, DWX, LVL, FGD and PID Zacks
09:07AM	How TEVAs CNS Drugs Performed in 1H17 Market Realist
Sep-13-17 01:27PM	5 Hot Global Dividend ETFs Zacks
10:37AM	How TEVAs Generic Medicines Franchise Is Positioned after 1H17 Market Realist
Sep-11-17 12:32PM	How ONEOK Has Managed Its Impressive Dividend Yield Market Realist
Aug-30-17 06:06PM	What Happened to Novartiss Innovative Medicines Business in 2Q17? Market Realist
02:11PM	Global Dividend Payments Upbeat in Q2: ETFs to Benefit Zacks
Aug-23-17 12:42PM	Dividend Yield of Stanley Black & Decker Market Realist
Aug-18-17 10:37AM	A Look at Sanofi Pasteurs Performance in 2Q17 Market Realist
07:37AM	North America: Fresenius Medical Cares Major Target Market in 2017 Market Realist
Aug-17-17 09:07AM	Sanofi Genzyme Continues Driving Revenue Growth in 2Q17 Market Realist
Aug-16-17 09:32AM	Kimberly-Clarks Dividend Growth Market Realist
Jul-25-17 07:39AM	Novartis in 2Q17: Performance of Sandoz Market Realist
Jul-17-17 12:05PM	Analysts Expect Novartiss Revenues to Fall in 2Q17 Market Realist
Jun-13-17 10:36AM	What Makes This Global Dividend Income ETF So Popular Zacks
Jun-01-17 09:09AM	Inside Novartiss Segment-Wise Performance in 1Q17 Market Realist
May-29-17 09:06AM	Performance of Sanofis Established Prescription Products in 1Q17 Market Realist
May-02-17 12:00PM	Don't Sell, Buy 4 High Dividend ETFs Under $20 in May Zacks
09:07AM	How GlaxoSmithKlines Vaccines Business Performed in 1Q17 Market Realist
May-01-17 07:40AM	How GlaxoSmithKlines Business Segments Performed in 1Q17 Market Realist
Apr-27-17 05:05PM	Novartiss 1Q17 Earnings: Innovative Medicines Segment Market Realist
Apr-26-17 07:36AM	GlaxoSmithKlines 1Q17 Estimates: Vaccines Business Market Realist
Apr-24-17 10:37AM	Analyst Ratings and Recommendations for Novartis Market Realist
Apr-21-17 01:13PM	Analyst Estimates for Novartiss 1Q17 Earnings Market Realist
Apr-04-17 07:36AM	Novartis Expects to Restore Alcons Profitability in the Future Market Realist
07:36AM	Novartis Expects to Restore Alcons Profitability in the Future
Apr-03-17 07:37AM	Sanofi Genzyme Continued Growth in 2016 Market Realist
07:37AM	Sanofi Genzyme Continued Growth in 2016
Mar-30-17 10:36AM	Reduced Co-pays May Boost Demand for Entresto Market Realist
10:36AM	Reduced Co-pays May Boost Demand for Entresto
07:36AM	Performance of GlaxoSmithKlines Vaccines Business in 2016 Market Realist
07:36AM	Performance of GlaxoSmithKlines Vaccines Business in 2016
Mar-29-17 07:37AM	GlaxoSmithKlines Pharmaceuticals Segment Performance Market Realist
07:37AM	GlaxoSmithKlines Pharmaceuticals Segment Performance
Mar-28-17 02:56PM	With low yields abroad, investors hunt for international dividend funds MarketWatch
Mar-27-17 10:37AM	Sandoz: Novartiss Generics Business in 2016 Market Realist
10:37AM	Sandoz: Novartiss Generics Business in 2016
09:08AM	Novartiss Innovative Medicines Segment in 2016 Market Realist
09:08AM	Novartiss Innovative Medicines Segment in 2016
Feb-21-17 10:36AM	What Happened to Sanofis Valuation after 4Q16? Market Realist
10:36AM	What Happened to Sanofis Valuation after 4Q16?
Feb-20-17 07:37AM	This Keeps Driving Sanofis Growth
Feb-16-17 07:35AM	GlaxoSmithKlines Consumer Healthcare Reports Growth in 4Q16
Feb-15-17 10:36AM	GlaxoSmithKlines Vaccines Business Reported Growth in 4Q16
Feb-14-17 01:35PM	4Q16 Performance of GlaxoSmithKlines Business Segments
Feb-01-17 04:35PM	Novartiss Innovative Medicines Segment in 4Q16
Jan-30-17 10:36AM	PotashCorp in 4Q16: Nitrogen Prices Added Salt to the Wound
Jan-23-17 09:07AM	Novartiss 4Q16 Estimates: Innovative Medicines Segment
Jan-17-17 09:06AM	How Did Novartiss Generics Business Perform in 3Q16?
Dec-30-16 09:07AM	How GlaxoSmithKlines Pharmaceuticals Segment Has Performed
Dec-14-16 09:30AM	The Zacks Analyst Blog Highlights: Guggenheim S&P Global Dividend Opportunities Index ETF, PowerShares International Dividend Achievers Portfolio, PowerShares High Yield Equity Dividend Achievers Portfolio and AdvisorShares Athena High Divi
Dec-13-16 11:05AM	4 High Dividend ETFs Under $20
Nov-23-16 04:01PM	PowerShares Announces Listing Transfer for 27 ETFs PR Newswire
Nov-17-16 11:04AM	How Sandoz Performed for Novartis in 3Q16
Nov-03-16 10:04AM	How Tresiba Helps Novo Achieve Its Growth Targets
08:04AM	Victoza Dominates Global GLP-1 Class
Nov-02-16 11:04AM	Reading Novos Insulin Portfolio to Find Clues about Its Growth
Nov-01-16 06:04PM	US Still the Largest Market for Novo Nordisk
08:04AM	Why Did PotashCorps Nitrogen Prices Fall in 3Q16?
Oct-25-16 10:52AM	How Much Is the Return Opportunity for Novo Nordisk in 3Q16?
Oct-24-16 11:04AM	Novartiss 3Q16 Estimates: Will Alcon Recover Its Growth?
08:05AM	Novartiss 3Q16 Estimates: Innovative Medicines Segment
Oct-20-16 09:44AM	5 Best Smart Beta ETFs That Pay Dividends (PID, ICF) Investopedia
Oct-07-16 01:16PM	Is the Dividend ETF Bull Run Over?
Oct-06-16 09:00AM	International Dividend ETFs Remain Solid Ideas
Oct-03-16 10:04AM	Novo Nordisk Expects to Witness Strong Growth from New Product Launches
Sep-30-16 06:04PM	Novo Nordisk Is Expected to See Strong Growth in Insulin Segment
Sep-29-16 05:04PM	Novo Nordisk Is Focusing on These Strategic Areas in 2016
Sep-28-16 11:04AM	Tevas Share of the US Generics Market Could Boost Its Stock
Sep-26-16 11:05AM	Winning? We Review How Teva Dominates Generic Drug Space
Sep-15-16 11:04AM	Sanofis Chase for Zika Virus Vaccine Could Drive Its Share Price
08:04AM	Will Sanofi See More Growth from Its Blockbuster Insulin Drug?
Sep-13-16 11:04AM	GSK Optimistic about Future of Its Consumer Healthcare Segment
10:04AM	GlaxoSmithKline Giving a Shot to Its Vaccines Business
Sep-12-16 11:04AM	GlaxoSmithKlines Combo Treatment for HIV Faces Stiff Competition
Sep-08-16 12:27PM	5 Undervalued ETFs for Dividend Lovers
11:18AM	Analyzing Sanofis Asset Swap Deal with Boehringer Ingelheim
Aug-22-16 11:04AM	Teva Pharmaceutical: A Successful Bond Financing Program in 2016
11:04AM	How Merial Contributes to Sanofis Growth
Aug-19-16 11:04AM	What Happened to Sanofis Consumer Healthcare and Generics Franchise in 2Q16?
Aug-18-16 11:04AM	Behind Sanofis Diabetes and Cardiovascular Performance in 2Q16
09:06AM	Genzyme Continued to Boost Growth for Sanofi in 2Q16
Aug-17-16 05:05PM	Inside Sanofis Valuation Changes
Aug-09-16 03:40PM	How Did Novo Nordisk Perform across Geographies in 1H16?
Aug-08-16 10:09AM	A New Low Volatility International ETF for Dividend Lovers
10:09AM	A New Low Volatile International ETF for Dividend Lovers
Aug-05-16 11:07AM	An Update on Shires Upcoming Milestones
Aug-02-16 09:07AM	How Did GlaxoSmithKlines Pharmaceuticals Segment Do in 2Q16?
Aug-01-16 04:47PM	How Much Growth Will Novo See in 2Q16?
Jul-30-16 08:40PM	GlaxoSmithKline Increases Top Line in 2Q16

The investment seeks to track the investment results (before fees and expenses) of the NASDAQ International Dividend AchieversTM Index. The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of Global Depositary Receipts ("GDRs") that are listed on the London Stock Exchange ("LSE") or the London International Exchange, and American Depositary Receipts ("ADRs") and non-U.S. common or ordinary stocks, limited partnership interests and shares of limited liability companies that are listed on the NYSE.

open in yahoo | open in google

Upgrade your FINVIZ experience